Co-Diagnostics, Inc. Appoints Richard Abbott As President, Concurrent With The Co Naming David Nielsen To Be Its Chief Operations Officer

Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that

BenzingaApr 4 09:31 ET

Co-Diagnostics Names David Nielsen as Chief Ops Officer and Christopher Thurston as Chief Technology Officer >CODX

Co-Diagnostics Names David Nielsen as Chief Ops Officer and Christopher Thurston as Chief Technology Officer >CODX

Dow JonesApr 4 09:31 ET

Press Release: Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions PR Newswire SALT LAKE CITY, April 4, 2024 SALT LAKE CITY, April 4, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (

Dow JonesApr 4 09:30 ET

Co-Diagnostics: Richard Abbott Appointed as Pres >CODX

Co-Diagnostics: Richard Abbott Appointed as Pres >CODX

Dow JonesApr 4 09:30 ET

Peering Into Co-Diagnostics's Recent Short Interest

Co-Diagnostics's (NYSE:CODX) short percent of float has risen 12.61% since its last report. The company recently reported that it has 381 thousand shares sold short, which is 1.25% of all regular shar

BenzingaApr 2 13:45 ET

Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development...

PR NewswireMar 21 09:30 ET